These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 27470137)

  • 1. Diurnal glycemic fluctuation is associated with severity of coronary artery disease in prediabetic patients: Possible role of nitrotyrosine and glyceraldehyde-derived advanced glycation end products.
    Watanabe M; Kawai Y; Kitayama M; Akao H; Motoyama A; Wakasa M; Saito R; Aoki H; Fujibayashi K; Tsuchiya T; Nakanishi H; Saito K; Takeuchi M; Kajinami K
    J Cardiol; 2017 Apr; 69(4):625-631. PubMed ID: 27470137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postchallenge responses of nitrotyrosine and TNF-alpha during 75-g oral glucose tolerance test are associated with the presence of coronary artery diseases in patients with prediabetes.
    Chu CS; Lee KT; Cheng KH; Lee MY; Kuo HF; Lin TH; Su HM; Voon WC; Sheu SH; Lai WT
    Cardiovasc Diabetol; 2012 Mar; 11():21. PubMed ID: 22397368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of glycemic variability and glycated hemoglobin as risk factors of coronary artery disease in patients with undiagnosed diabetes.
    Mi SH; Su G; Li Z; Yang HX; Zheng H; Tao H; Zhou Y; Tian L
    Chin Med J (Engl); 2012 Jan; 125(1):38-43. PubMed ID: 22340463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of daily glucose fluctuations on cardiovascular outcomes after percutaneous coronary intervention for patients with stable coronary artery disease undergoing lipid-lowering therapy.
    Yamamoto H; Shinke T; Otake H; Kawamori H; Toba T; Kuroda M; Hirota Y; Sakaguchi K; Ogawa W; Hirata KI
    J Diabetes Investig; 2021 Jun; 12(6):1015-1024. PubMed ID: 33098191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes.
    Su G; Mi S; Tao H; Li Z; Yang H; Zheng H; Zhou Y; Ma C
    Cardiovasc Diabetol; 2011 Feb; 10():19. PubMed ID: 21349201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased serum concentrations of pentosidine are related to presence and severity of coronary artery disease.
    Kerkeni M; Weiss IS; Jaisson S; Dandana A; Addad F; Gillery P; Hammami M
    Thromb Res; 2014 Sep; 134(3):633-8. PubMed ID: 25065554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is mean platelet volume associated with the angiographic severity of coronary artery disease?
    Ekici B; Erkan AF; Alhan A; Sayın I; Aylı M; Töre HF
    Kardiol Pol; 2013; 71(8):832-8. PubMed ID: 24049023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of daily glucose fluctuation on coronary plaque vulnerability in patients pre-treated with lipid-lowering therapy: a prospective observational study.
    Kuroda M; Shinke T; Sakaguchi K; Otake H; Takaya T; Hirota Y; Sugiyama D; Nakagawa M; Hariki H; Inoue T; Osue T; Taniguchi Y; Iwasaki M; Nishio R; Kinutani H; Konishi A; Hiranuma N; Takahashi H; Terashita D; Hirata KI
    JACC Cardiovasc Interv; 2015 May; 8(6):800-811. PubMed ID: 25999102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiographic evaluation of the effects of glucose metabolic status on progression of coronary artery lesions in patients with coronary artery disease.
    Wang H; Tang Z; Li X; Hu B; Feng B
    J Diabetes; 2014 Nov; 6(6):541-6. PubMed ID: 24981702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-hour post-challenge hyperglycemia, but not fasting plasma glucose, associated with severity of coronary artery disease in patients with angina.
    Fu CP; Sheu WH; Lee WL; Lee WJ; Wang JS; Lin SY; Lee IT
    PLoS One; 2018; 13(8):e0202280. PubMed ID: 30110378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced glycation end products in nondiabetic patients with coronary artery disease.
    Kanauchi M; Tsujimoto N; Hashimoto T
    Diabetes Care; 2001 Sep; 24(9):1620-3. PubMed ID: 11522709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose fluctuation and the resultant endothelial injury are correlated with pancreatic β cell dysfunction in patients with coronary artery disease.
    Murata M; Adachi H; Oshima S; Kurabayashi M
    Diabetes Res Clin Pract; 2017 Sep; 131():107-115. PubMed ID: 28743060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum pentraxin 3 levels are associated with the complexity and severity of coronary artery disease in patients with stable angina pectoris.
    Karakas MF; Buyukkaya E; Kurt M; Motor S; Akcay AB; Buyukkaya S; Karakas E; Bilen P; Sen N
    J Investig Med; 2013 Feb; 61(2):278-85. PubMed ID: 23237880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SYNTAX score-0 patients: risk stratification in nonobstructive coronary artery disease.
    Sinning C; Zengin E; Waldeyer C; Seiffert M; Schnabel RB; Lubos E; Zeller T; Bickel C; Blankenberg S; Clemmensen PM; Westermann D
    Clin Res Cardiol; 2016 Nov; 105(11):901-911. PubMed ID: 27364941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between serum uric acid level and the severity of coronary artery disease in patients with obstructive coronary artery disease.
    Yu J; Han J; Mao J; Guo L; Gao W
    Chin Med J (Engl); 2014; 127(6):1039-45. PubMed ID: 24622431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severity of stable coronary artery disease and its biomarkers differ between men and women undergoing angiography.
    Gijsberts CM; Gohar A; Ellenbroek GH; Hoefer IE; de Kleijn DP; Asselbergs FW; Nathoe HM; Agostoni P; Rittersma SZ; Pasterkamp G; Appelman Y; den Ruijter HM
    Atherosclerosis; 2015 Jul; 241(1):234-40. PubMed ID: 25670231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between the Finnish Diabetes risk Score and the severity of coronary artery disease.
    Djurić P; Mladenović Z; Grdinić A; Tavčiovski D; Spasić M; Davičević-Elez Z
    Vojnosanit Pregl; 2014 May; 71(5):474-80. PubMed ID: 26137713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between the serum alkaline phosphatase level and the severity of coronary artery disease.
    Sahin I; Karabulut A; Gungor B; Avci II; Okuyan E; Kizkapan F; Yildiz SS; Can MM; Dinckal M
    Coron Artery Dis; 2014 Jun; 25(4):349-52. PubMed ID: 24769515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary severity score and C-reactive protein predict major adverse cardiovascular events in patients with stable coronary artery disease (from the Taichung CAD study).
    Pan HC; Sheu WH; Lee WJ; Lee WL; Liao YC; Wang KY; Lee IT; Wang JS; Liang KW
    Clin Chim Acta; 2015 May; 445():93-100. PubMed ID: 25818243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial function and baroreflex sensitivity according to the oral glucose tolerance test in patients with coronary artery disease and normal fasting glucose levels.
    Wykretowicz A; Guzik P; Bartkowiak G; Krauze T; Kasinowski R; Dziarmaga M; Wesseling KH; Wysocki H
    Clin Sci (Lond); 2005 Oct; 109(4):397-403. PubMed ID: 15948715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.